Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
295
NCT00035880
Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease
Phase: Phase 2/3
Role: Lead Sponsor
Start: Oct 31, 1999
Completion: Jun 30, 2003
NCT00035828
A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD
Phase: Phase 2
Start: Dec 31, 2001
Completion: Dec 31, 2002
NCT00061126
ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body
Start: Apr 30, 2003
Completion: Not specified